The Latest Cardiac and Vascular News
Appointments to scale adoption of Caristo’s AI-powered cardiovascular technologies globally OXFORD, England and STAMFORD, Conn., July 23, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in AI-powered technologies for cardiovascular disease, today announced two additions to its…
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo’s technologies, including—for the first time—an application of FAI-Score on non-contrast cardiac CT OXFORD, England and STAMFORD, Conn., July 8, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in…
Caristo’s flagship technology, CaRi-Heart, recognised for its groundbreaking ability to transform cardiovascular disease prevention and management Caristo joins a prestigious group of 100 global innovators chosen by the World Economic Forum to help solve major world challenges OXFORD,…
OXFORD, England and STAMFORD, Conn., April 14, 2026 /PRNewswire/ — Caristo Diagnostics, a University of Oxford spinout and a global leader in AI technology for cardiovascular disease, today announced the appointment of Board Member Stephen M. Deitsch as Chief Executive Officer (CEO),…
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease,…
Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology NCH cardiologists to present collaboration plans at American Heart Association 2025 Scientific Sessions on Nov. 8 NAPLES, Fla. and STAMFORD, Conn. , Nov. 5, 2025 /PRNewswire/ — Naples…
AMA assigns CPT codes 0992T and 0993T to Caristo’s CaRi-Heart® AI-powered analysis of perivascular fat and cardiovascular risk, which are included in the 2026 CPT® Codebook New CPT codes mark a major step toward making CaRi-Heart technology available in everyday clinical care in the U.S….
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring STAMFORD, Conn. and LOS ANGELES, Sept. 16, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis…
FAI-Score has stronger predictive value than hsCRP for 10-year cardiac death, even among those with zero calcium score and no visible coronary plaque In patients with low hsCRP, high FAI-Score predicts 7-fold higher risk of cardiac death OXFORD, England, Sept. 11, 2025 /PRNewswire/ –…
New data shows CaRi-Heart FAI-Score technology predicts cardiac risk—even in patients with low or zero calcium scores, traditionally considered low-risk CaRi-Heart results from large-scale implementation at five National Health Service (NHS) hospitals in the UK will be presented STAMFORD,…
